Zurueck zur Suche

Reporte zur Charge U8201EA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

7Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
PA 2 IL 1 WI 1 OH 1 MD 1 MA 1

VAERS 2725907

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8201EA

schwer
Staat
IL
Alter
41,0
Geschlecht
M
Eingang
20.12.2023
Impfdatum
19.12.2023
Beginn
19.12.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Loss of consciousness Urinary incontinence

Symptomtext

Patient briefly passed out, in the immunizing chair in our immunizing booth, once he received both vaccinations in his left arm (patient did not want them in separate arms.) He urinated on himself and immediately regained consciousness.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
Cefzil
Vorherige Impfungen
-

VAERS 2722961

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8201EA

mild
Staat
WI
Alter
48,0
Geschlecht
M
Eingang
11.12.2023
Impfdatum
30.11.2023
Beginn
30.11.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site discharge No adverse event

Symptomtext

half of the vaccine leaked out of the injection site with no reported adverse event; Initial information received on 30-Nov-2023 regarding an unsolicited valid non-serious case received via pharmacist. This case involves a 48-year-old male patient and the reporter stated influenza quadrival A-B vaccine [Fluzone QIV] half of the vaccine leaked out of the injection site with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 30-Nov-2023, the patient received a 0.5 ml dose of suspect influenza quadrival A-B vaccine, suspension for injection (strength: unknown) (lot: U8201EA, Expiry date: 20-Jun-2024) via intramuscular route in the right deltoid for immunization and half of the vaccine leaked out of the injection site with no reported adverse event (incorrect dose administered) (latency: same day) Reportedly, he administered the medication to the patient, there was no issues or leakage during the medication preparation, but when he injected it into the patient's deltoid, for some reason, perhaps it was because of the patient's body fat or body mass said the pharmacist, approximately half of the vaccine leaked out of the injection site. Pharmacist also asks if they should use the alternate deltoid as the injection site for re-vaccination This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site discharge
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2720222

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8201EA

mild
Staat
PA
Alter
5,0
Geschlecht
M
Eingang
01.12.2023
Impfdatum
26.11.2023
Beginn
26.11.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site movement impairment Peripheral swelling

Symptomtext

Per patient's mother, arm because so swollen after vaccination that he could not lift his arm. He had to be evaluated by his pediatrician. As of 12/1/23 mom said reaction has improved.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site movement impairment
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
no known
Vorgeschichte
no known
Andere Medikamente
n/a
Allergien
no known allergies
Vorherige Impfungen
-

VAERS 2717608

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8201EA

mild
Staat
PA
Alter
31,0
Geschlecht
F
Eingang
24.11.2023
Impfdatum
14.11.2023
Beginn
14.11.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Pain

Symptomtext

Patient states having left shoulder pain continuing 1 week after vaccination. She is experiencing pain when lifting her left arm.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
No Known Allergies
Vorherige Impfungen
-

VAERS 2719997

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8201EA

gering
Staat
OH
Alter
0,6
Geschlecht
F
Eingang
01.12.2023
Impfdatum
29.11.2023
Beginn
01.11.2023
Tage bis Beginn
-
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Electroencephalogram Posture abnormal

Symptomtext

The patient reported to emergency room at 18:41 on 11/29/2023. The Parent reported to ER staff at intake patient t with a left-sided head drop beginning on Monday 11-27-2023. No color change or eye deviation during episodes per father. The patient has roughly one episode per day. Episodes roughly last 30 seconds, with 1-4 head drops.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Electroencephalogram
Hospital-Tage
1,0
Labordaten
Hospital performed long term monitoring EEG
Aktuelle Erkrankungen
At the time the vaccine was administered there were not any reported
Vorgeschichte
-
Andere Medikamente
famotidine 40 mg/5ml take 0.45 ml twice daily
Allergien
No, Know Allergies
Vorherige Impfungen
-

VAERS 2719956

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge U8201EA

gering
Staat
MD
Alter
0,6
Geschlecht
F
Eingang
01.12.2023
Impfdatum
14.11.2023
Beginn
14.11.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration No adverse event

Symptomtext

The patient received her first influenza vaccine on 11/4/23 and was scheduled by the staff to come back 10 days later for her 2nd dose, not 4 weeks later so she received the 2nd dose too soon. She had no adverse reactions from the second dose.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2696533

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge U8201EA

gering
Staat
MA
Alter
42,0
Geschlecht
F
Eingang
16.10.2023
Impfdatum
13.10.2023
Beginn
14.10.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Swelling face

Symptomtext

Facial swelling over night after vaccine

Weitere VAERSDATA-Felder
Praegender Schweregrund
Swelling face
Hospital-Tage
-
Labordaten
Pt reports going to urgent care who recommended benadryl and speaking with PCP who prescribed oral steroid
Aktuelle Erkrankungen
Denies
Vorgeschichte
Denies
Andere Medikamente
Denies
Allergien
Ibuprofen
Vorherige Impfungen
-